Aripiprazole use and lowering the risk of breast cancer in patient with schizophrenia in a national cohort study
Saved in:
| Main Authors: | Po-Hsun Hou, Gung-Ruei Chang, Ying-Ting Chao, Yu-Teng Chang, Da-Han Hou, Shiau-Shian Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12136300/?tool=EBI |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01) -
A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
by: Lakshmi Priya, et al.
Published: (2021-01-01) -
Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia
by: Suneeta James, et al.
Published: (2016-01-01) -
Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01) -
Corrigendum to “Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia”
by: Suneeta James, et al.
Published: (2019-01-01)